Picture of Cyclo Therapeutics logo

CYTH — Cyclo Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapMomentum Trap

Cyclo Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary

* Cyclo Therapeutics Inc  CYTH.OQ  reported a quarterly
adjusted
loss of 27 cents​​ per share for the quarter ended September 30,
higher than the same quarter last year, when the company
reported EPS of -29 cents.  The mean expectation of
three analysts for the quarter was for a loss of 16 cents per
share. Wall Street expected results to range from -19 cents
to -13 cents per share.
    * Revenue fell 53% to $233.00 thousand from a year ago;
analysts
expected $294.00 thousand. 
    * Cyclo Therapeutics Inc's reported EPS for the quarter was
a loss
of 31 cents​.
    * The company reported a quarterly loss of $8.83 million.
    * Cyclo Therapeutics Inc shares had fallen by 8.7% this
quarter and lost 54.7% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 5% in
the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the
pharmaceuticals
peer group is also "hold"

Wall Street's median 12-month price target for Cyclo
Therapeutics Inc is $0.95 
This summary was machine generated from LSEG data November 14 at
08:55 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -0.16          -0.27          Missed
 Jun. 30 2024      -0.15          -0.21          Missed
 Mar. 31 2024      -0.20          -0.15          Beat
                                  -0.34

Recent news on Cyclo Therapeutics

See all news